|
SFRS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.316100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.561000E-03 |
| Normal-vs-Stage2 |
1.196380E-01 |
| Normal-vs-Stage3 |
3.200400E-02 |
| Normal-vs-Stage4 |
2.360300E-02 |
| Stage1-vs-Stage2 |
7.268000E-01 |
| Stage1-vs-Stage3 |
8.372400E-01 |
| Stage1-vs-Stage4 |
9.685000E-01 |
| Stage2-vs-Stage3 |
8.747000E-01 |
| Stage2-vs-Stage4 |
7.469400E-01 |
| Stage3-vs-Stage4 |
8.533400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.458200E-02 |
| Normal-vs-AfricanAmerican |
1.68205999999671E-05 |
| Normal-vs-Asian |
8.150200E-02 |
| Caucasian-vs-AfricanAmerican |
2.12899999999516E-05 |
| Caucasian-vs-Asian |
1.209200E-01 |
| AfricanAmerican-vs-Asian |
3.837400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.126560E-01 |
| Normal-vs-Female |
4.34579999986084E-07 |
| Male-vs-Female |
1.7345199999963E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.599600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.544500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.858200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.110850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.062600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.973200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.243800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.914000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.708200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.325600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.7749999999569E-06 |
| Normal-vs-Grade 2 |
6.227700E-04 |
| Normal-vs-Grade 3 |
4.238500E-02 |
| Normal-vs-Grade 4 |
1.079770E-01 |
| Grade 1-vs-Grade 2 |
4.829900E-02 |
| Grade 1-vs-Grade 3 |
6.496700E-03 |
| Grade 1-vs-Grade 4 |
4.986300E-02 |
| Grade 2-vs-Grade 3 |
1.157420E-01 |
| Grade 2-vs-Grade 4 |
4.756400E-01 |
| Grade 3-vs-Grade 4 |
7.506000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.169400E-04 |
| Normal-vs-ccB subtype |
3.754000E-01 |
| ccA subtype-vs-ccB subtype |
8.719100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.244230E-02 |
| Normal-vs-N1 |
3.332800E-01 |
| N0-vs-N1 |
8.079200E-01 |
|
|
